Manthey M K, Huang D T, Bubb W A, Christopherson R I
Department of Biochemistry, University of Sydney, Sydney, NSW 2006, Australia.
J Med Chem. 1998 Nov 5;41(23):4550-5. doi: 10.1021/jm970814z.
The design, synthesis, and enzymic evaluation of cis- and trans-4-mercapto-6-oxo-1,4-azaphosphinane-2-carboxylic acid 4-oxide 5 against mammalian dihydroorotase is presented. The design strategy for 5 was based on the strong affinity of phosphinothioic acids for zinc and that 5 also resembles the postulated tetrahedral transition state for the enzyme-catalyzed reaction. The synthesis of 5 utilized a novel protection/deprotection sequence upon 4-hydroxy-6-oxo-1, 4-azaphosphinane-2-carboxylic acid 4-oxide 4, followed by incorporation of alpha-phenyl benzenemethanethiol and exhaustive deprotection to afford 5 in 40% overall yield from 4. The activities of both isomers of 5 as inhibitors of mammalian dihydroorotase were marginally greater than that of the parent phosphinic acid 4, indicating a weak binding enhancement due to the phosphinothioic acid moiety.
本文介绍了顺式和反式-4-巯基-6-氧代-1,4-氮杂磷杂环庚烷-2-羧酸4-氧化物5针对哺乳动物二氢乳清酸酶的设计、合成及酶活性评估。5的设计策略基于硫代次膦酸对锌的强亲和力,且5也类似于酶催化反应假定的四面体过渡态。5的合成利用了4-羟基-6-氧代-1,4-氮杂磷杂环庚烷-2-羧酸4-氧化物4上的新型保护/脱保护序列,随后引入α-苯基苯甲硫醇并进行彻底脱保护,以4为原料总收率40%得到5。5的两种异构体作为哺乳动物二氢乳清酸酶抑制剂的活性略高于母体次膦酸4,表明硫代次膦酸部分导致了弱的结合增强。